[1]曲瑞泽 综述 张志鹏**付卫**审校.肿瘤患者中心静脉导管相关血栓的成因和诊治研究进展[J].中国微创外科杂志,2022,01(3):246-250.
点击复制

肿瘤患者中心静脉导管相关血栓的成因和诊治研究进展()
分享到：

《中国微创外科杂志》[ISSN:1009-6604/CN:11-4526/R]

卷:
01
期数:
2022年3期
页码:
246-250
栏目:
文献综述
出版日期:
2022-06-02

文章信息/Info

作者:
曲瑞泽 综述 张志鹏**付卫**审校
(北京大学第三医院普外科，北京100191)
文献标志码:
A

参考文献/References:

[1]Farge D,Frere C,Connors JM,et al.2019 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer.Lancet Oncol,2019,20(10):e566-e581.
[2]陈雅玫,石新华,张煜.藻酸盐敷料在经外周静脉置入中心静脉导管后穿刺点止血中的对比研究.中国微创外科杂志,2017,17(7):606-608.
[3]Clark HH,Ballester L,Whitworth HB,et al.Prevention of recurrent thrombotic events in children with central venous catheterassociated venous thrombosis.Blood,2021 Nov 2.Online ahead of print.
[4]Chopra V,Anand S,Hickner A,et al.Risk of venous thromboembolism associated with peripherally inserted central catheters:a systematic review and metaanalysis.Lancet,2013,382(9889):311-325.
[5]Swaminathan L,Flanders S,Horowitz J,et al.Safety and outcomes of midline catheters vs peripherally inserted central catheters for patients with shortterm indications: a multicenter study.JAMA Intern Med,2022,182(1):50-58.
[6]中华医学会外科学分会血管外科学组.深静脉血栓形成的诊断和治疗指南(第三版).中国血管外科杂志(电子版),2017,9(4):250-257.
[7]Lurie JM,Png CYM,Subramaniam S,et al.Virchow’s triad in “silent” deep vein thrombosis.J Vasc Surg Venous Lymphat Disord,2019,7(5):640-645.
[8]Kahale LA,Tsolakian IG,Hakoum MB,et al.Anticoagulation for people with cancer and central venous catheters.Cochrane Database Syst Rev,2018,6(6):Cd006468.
[9]Mulder FI,HorváthPuhó E,van Es N,et al.Venous thromboembolism in cancer patients: a populationbased cohort study.Blood,2021,137(14):1959-1969.
[10]Park M,Qiu Y,Cao H,et al.Influence of hemodialysis catheter insertion on the hemodynamics in the central veins.J Biomech Eng,2020,142(9):091002.
[11]Peng L,Qiu Y,Huang Z,et al.Numerical simulation of hemodynamic changes in central veins after tunneled cuffed central venous catheter placement in patients under hemodialysis.Sci Rep,2017,7(1):15955.
[12]国际血管联盟中国分会,中国老年医学学会周围血管疾病管理分会.输液导管相关静脉血栓形成防治中国专家共识(2020版).中国实用外科杂志,2020,40(4):377-383.
[13]Wilson TJ,Brown DL,Meurer WJ,et al.Risk factors associated with peripherally inserted central venous catheterrelated large vein thrombosis in neurological intensive care patients.Intensive Care Med,2012,38(2):272-278.
[14]Morazin F,Kriegel I,Asselain B,et al.Symptomatic thrombosis in central venous catheter in oncology: a predictive score?Rev Med Interne,2005,26(4):273-279.
[15]Tesselaar ME,Ouwerkerk J,Nooy MA,et al.Risk factors for catheterrelated thrombosis in cancer patients.Eur J Cancer,2004,40(15):2253-2259.
[16]Kooij JD,van der Zant FM,van Beek EJ,et al.Pulmonary embolism in deep venous thrombosis of the upper extremity:more often in catheterrelated thrombosis.Neth J Med,1997,50(6):238-242.
[17]Rajasekhar A,Streiff MB.How I treat central venous access devicerelated upper extremity deep vein thrombosis.Blood,2017,129(20):2727-2736.
[18]Citla Sridhar D,AbouIsmail MY,Ahuja SP.Central venous catheterrelated thrombosis in children and adults.Thromb Res,2020,187:103-112.
[19]Baskin JL,Pui CH,Reiss U,et al.Management of occlusion and thrombosis associated with longterm indwelling central venous catheters.Lancet,2009,374(9684):159-169.
[20]Grant JD,Stevens SM,Woller SC,et al.Diagnosis and management of upper extremity deepvein thrombosis in adults.Thromb Haemost,2012,108(6):1097-1108.
[21]Bates SM,Jaeschke R,Stevens SM,et al.Diagnosis of DVT:antithrombotic therapy and prevention of thrombosis,9th ed:American College of Chest Physicians evidencebased clinical practice guidelines.Chest,2012,141(2 Suppl):e351S-e418S.
[22]Kakkos SK,Gohel M,Baekgaard N,et al.Editor’s choice:European Society for Vascular Surgery (ESVS) 2021 clinical practice guidelines on the management of venous thrombosis.Eur J Vasc Endovasc Surg,2021,61(1):9-82.
[23]Ghoneim A,Straiton J,Pollard C,et al.Imaging of cerebral venous thrombosis.Clin Radiol,2020,75(4):254-264.
[24]Debourdeau P,Farge D,Beckers M,et al.International clinical practice guidelines for the treatment and prophylaxis of thrombosis associated with central venous catheters in patients with cancer.J Thromb Haemost,2013,11(1):71-80.
[25]Liu W,He L,Zeng W,et al.Peripherally inserted central venous catheter in upper extremities leads to an increase in Ddimer and deep vein thrombosis in lower extremities.Thromb J,2021,19(1):24.
[26]NaezTerreros H,JaimePerez JC,MuozEspinoza LE,et al.Ddimer from central and peripheral blood samples in asymptomatic central venous catheterrelated thrombosis in patients with cancer.Phlebology,2019,34(1):52-57.
[27]Perrier A,Roy PM,Aujesky D,et al.Diagnosing pulmonary embolism in outpatients with clinical assessment,Ddimer measurement,venous ultrasound,and helical computed tomography:a multicenter management study.Am J Med,2004,116(5):291-299.
[28]van Belle A,Büller HR,Huisman MV,et al.Effectiveness of managing suspected pulmonary embolism using an algorithm combining clinical probability,Ddimer testing,and computed tomography.JAMA,2006,295(2):172-179.
[29]Schouten HJ,Geersing GJ,Koek HL,et al.Diagnostic accuracy of conventional or age adjusted Ddimer cutoff values in older patients with suspected venous thromboembolism:systematic review and metaanalysis.BMJ,2013,346:f2492.
[30]Habibollahi P,Zhang D,Kolber MK,et al.Venous thoracic outlet syndrome.Cardiovasc Diagn Ther,2021,11(5):1150-1158.
[31]Evans NS,Ratchford EV.Catheterrelated venous thrombosis.Vasc Med,2018,23(4):411-413.
[32]Hoggard J,Saad T,Schon D,et al.Guidelines for venous access in patients with chronic kidney disease.A position statement from the American Society of Diagnostic and Interventional Nephrology,Clinical Practice Committee and the Association for Vascular Access.Semin Dial,2008,21(2):186-191.
[33]Marin A,Bull L,Kinzie M,et al.Central catheterassociated deep vein thrombosis in cancer: clinical course,prophylaxis,treatment.BMJ Support Palliat Care,2021,11(4):371-380.
[34]Pelzer U,Opitz B,Deutschinoff G,et al.Efficacy of prophylactic lowmolecular weight heparin for ambulatory patients with advanced pancreatic cancer:outcomes from the CONKO004 Trial.J Clin Oncol,2015,33(18):2028-2034.
[35]Couban S,Goodyear M,Burnell M,et al.Randomized placebocontrolled study of lowdose warfarin for the prevention of central venous catheterassociated thrombosis in patients with cancer.J Clin Oncol,2005,23(18):4063-4069.
[36]Meyer G,Besse B,Doubre H,et al.Antitumour effect of low molecular weight heparin in localised lung cancer:a phase III clinical trial.Eur Respir J,2018,52(4):1801220.
[37]Lyman GH,Khorana AA,Falanga A,et al.American Society of Clinical Oncology guideline: recommendations for venous thromboembolism prophylaxis and treatment in patients with cancer.J Clin Oncol,2007,25(34):5490-5505.
[38]Schiffer CA,Mangu PB,Wade JC,et al.Central venous catheter care for the patient with cancer:American Society of Clinical Oncology clinical practice guideline.J Clin Oncol,2013,31(10):1357-1370.
[39]Matsuo K,Hom MS,Yabuno A,et al.Association of statins,aspirin,and venous thromboembolism in women with endometrial cancer.Gynecol Oncol,2019,152(3):605-611.
[40]Wallace A,Albadawi H,Hoang P,et al.Statins as a preventative therapy for venous thromboembolism.Cardiovasc Diagn Ther,2017,7(Suppl 3):S207-S218.
[41]Kearon C,Akl EA,Ornelas J,et al.Antithrombotic therapy for VTE disease:CHEST guideline and expert panel report.Chest,2016,149(2):315-352.
[42]Alsubaie NS,Al Rammah SM,Alshouimi RA,et al.The use of direct oral anticoagulants for thromboprophylaxis or treatment of cancerassociated venous thromboembolism:a metaanalysis and review of the guidelines.Thromb J,2021,19(1):76.
[43]Streiff MB,Holmstrom B,Angelini D,et al.NCCN guidelines insights:cancerassociated venous thromboembolic disease,version 2.2018.J Natl Compr Canc Netw,2018,16(11):1289-1303.
[44]Schindler J,Bona RD,Chen HH,et al.Regional thrombolysis with urokinase for central venous catheterrelated thrombosis in patients undergoing highdose chemotherapy with autologous blood stem cell rescue.Clin Appl Thromb Hemost,1999,5(1):25-29.
[45]Davies GA,LazoLangner A,Gandara E,et al.A prospective study of rivaroxaban for central venous catheter associated upper extremity deep vein thrombosis in cancer patients (catheter 2).Thromb Res,2018,162:88-92.
[46]Houghton DE,Billett HH,Gaddh M,et al.Risk of pulmonary emboli after removal of an upper extremity central catheter associated with a deep vein thrombosis.Blood Adv,2021,5(14):2807-2812.

备注/Memo

备注/Memo:
基金项目：国家自然科学基金面上项目(81672361)；国家卫生和计划生育委员会-中央保健局项目(2020YB57)；北京大学临床医学+X青年项目(PKU2021LCXQ001)**通讯作者，Email：fuwei@bjmu.edu.cn(付卫)；zhangzhipeng06@126.com(张志鹏)
更新日期/Last Update: 2022-06-02